Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KM-819 / Kainos Medicine
NCT05695378: Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)	Terminated	2	68	RoW	KM-819, Placebo	Kainos Medicine Inc., Parexel	Multiple System Atrophy	08/24	08/24
NCT05670782: A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants With Parkinson's Disease	Active, not recruiting	2	314	US	KM-819, Placebo	FAScinate Therapeutics Inc., Parexel	Parkinson Disease	10/25	11/25